KWM
BSX icon

Kingsview Wealth Management’s Boston Scientific BSX Stock Holding History

Kingsview Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$230K Sell
5,395
-1,621
-23% -$88K ﹤0.01% 1299
2026
Q1 		$440K Buy
7,016
+950
+16% +$76K 0.01% 945
2025
Q4 		$578K Buy
6,066
+142
+2% +$13.9K 0.01% 795
2025
Q3 		$578K Buy
5,924
+731
+14% +$75.7K 0.01% 760
2025
Q2 		$558K Sell
5,193
-1,542
-23% -$156K 0.01% 737
2025
Q1 		$679K Buy
6,735
+172
+3% +$17.3K 0.01% 635
2024
Q4 		$586K Buy
6,563
+593
+10% +$52.2K 0.01% 692
2024
Q3 		$500K Buy
5,970
+282
+5% +$22.2K 0.01% 724
2024
Q2 		$438K Buy
5,688
+118
+2% +$8.64K 0.01% 726
2024
Q1 		$381K Buy
5,570
+219
+4% +$14.1K 0.01% 738
2023
Q4 		$309K Sell
5,351
-4,415
-45% -$236K 0.01% 757
2023
Q3 		$516K Sell
9,766
-168
-2% -$8.81K 0.02% 612
2023
Q2 		$537K Buy
9,934
+361
+4% +$18.9K 0.02% 568
2023
Q1 		$479K Buy
9,573
+3,799
+66% +$179K 0.02% 586
2022
Q4 		$267K Buy
5,774
+167
+3% +$7.23K 0.01% 701
2022
Q3 		$217K Buy
5,607
+175
+3% +$7.02K 0.01% 734
2022
Q2 		$202K Sell
5,432
-2,040
-27% -$83K 0.01% 764
2022
Q1 		$331K Sell
7,472
-3,600
-33% -$156K 0.01% 668
2021
Q4 		$470K Hold
11,072
– – 0.02% 593
2021
Q3 		$480K Buy
11,072
+1,400
+14% +$61.9K 0.02% 558
2021
Q2 		$419K Buy
+9,672
New +$407K 0.02% 609

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kingsview Wealth Management's BSX Position: Q2 2026 in Review

Kingsview Wealth Management reduced its Boston Scientific (BSX) stake by 23% in Q2 2026, selling an estimated $88K and leaving 5,395 shares worth $230K. The position accounts for ﹤0.01% of the portfolio, ranked #1299.

Kingsview Wealth Management first reported a position in BSX in Q2 2021 and has held it in 21 quarters since. The position peaked at $679K in Q1 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Kingsview Wealth Management held 5,395 shares of Boston Scientific worth $230K as of Q2 2026.
  • Kingsview Wealth Management sold 1,621 Boston Scientific shares in Q2 2026, an estimated $88K.
  • Boston Scientific made up ﹤0.01% of Kingsview Wealth Management's portfolio in Q2 2026, its #1299 holding.
  • Kingsview Wealth Management first reported a position in Boston Scientific in Q2 2021 and has held it in 21 quarters since.
  • Kingsview Wealth Management's Boston Scientific position peaked at $679K in Q1 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Kingsview Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.